Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 5 High Risk/Reward Biotechs For 2012
5 High Risk/Reward Biotechs For 2012
5 High Risk/Reward Biotechs For 2012
Submitted by
admin
on December 5, 2011 - 6:13pm
Source:
Seeking Alpha
News Tags:
ONYX Pharmaceuticals
Vertex Pharmaceuticals
Amarin
Chelsea Therapeutics
Cell Therapeutics
Headline:
5 High Risk/Reward Biotechs For 2012
Do Not Allow Advertisers to Use My Personal information
